Kempers and colleagues (2011) in their studies established different cancer risks associated with EPCAM deletions, depending on whether a deletion affects only the EPCAM gene or both the EPCAM and its neighboring gene MSH2 (EPCAM-MSH2). Here, MSH2 is linked to cancer.